Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 22;34(4):566-78.
doi: 10.1016/j.immuni.2011.03.018.

Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation

Affiliations

Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation

Ashutosh Chaudhry et al. Immunity. .

Abstract

Effector CD4+ T cell subsets, whose differentiation is facilitated by distinct cytokine cues, amplify the corresponding type of inflammatory response. Regulatory T (Treg) cells integrate environmental cues to suppress particular types of inflammation. In this regard, STAT3, a transcription factor essential for T helper 17 (Th17) cell differentiation, is necessary for Treg cell-mediated control of Th17 cell responses. Here, we showed that anti-inflammatory interleukin-10 (IL-10), and not proinflammatory IL-6 and IL-23 cytokine signaling, endowed Treg cells with the ability to suppress pathogenic Th17 cell responses. Ablation of the IL-10 receptor in Treg cells resulted in selective dysregulation of Th17 cell responses and colitis similar to that observed in mice harboring STAT3-deficient Treg cells. Thus, Treg cells limit Th17 cell inflammation by serving as principal amplifiers of negative regulatory circuits operating in immune effector cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1. IL-10 induces robust STAT3 phosphorylation in Treg cells
(A) Flow cytometric analysis of pSTAT3 (Y705) amounts after treatment of splenic CD4+Foxp3- T cells, CD4+Foxp3+ Treg cells and CD8 T cells with recombinant IL-6 (16 ng/ml) or IL-10 (100 ng/ml) for 15 mins. Analysis of pSTAT3 levels by either flow cytometry (B) or western blotting (C) after stimulation of indicated cells with titrating doses (3, 10 and 15 ng/ml for IL-6; 50, 150 and 300 ng/ml for IL-10) of recombinant IL-6 or IL-10. (D) Immunoblot detection of pSTAT3 and STAT3 in Treg cells isolated from IL-10R or IL-6R deficient and sufficient mice. Data are representative of four independent experiments.
Figure 2
Figure 2. Treg cell-specific IL-10R deletion results in severe intestinal inflammation
(A, B) Spleen and lymph node cellularity in Foxp3CreIl10rafl/wt and Foxp3CreIl10rafl/fl mice (** p<0.001; * p<0.01). (C, D) Frequencies of activated T cells (E, F) Absolute numbers of CD4+Foxp3+ T cells and (G) body weights of Foxp3CreIl10rafl/fl mice (n=7). (H) IBD scores derived from evaluation of colon and cecum from 14-16 week-old Foxp3CreIl10rafl/wt and Foxp3CreIl10rafl/fl mice (n=4/group). (I) Representative H&E stained sections of large bowel at the level of the ileocecal-colic junction from Foxp3CreIl10rafl/wt and Foxp3CreIl10rafl/fl mice. Note: Mucosa (M) with expanded irregular, hyperplastic crypts, glandular loss and fibrosis with multifocal transmural inflammation (arrow). Lumen (L). Original magnification, 5x (n=7).
Figure 3
Figure 3. IL-10R ablation does not affect Foxp3 expression and Treg cell lineage stability
(A) Flow cytometric analysis of Foxp3 and YFP expression on splenic CD4+ T cells in Foxp3CreIl10rafl/flR26Y and control littermate mice. (B) Expression of Foxp3 in flow cytometry-sorted CD4+YFP+ T cells from indicated mice. (C) Quantitative PCR (qPCR) analysis of Foxp3 and IL-10Rα expression in flow cytometry-sorted CD4+YFP+ T cells. The grey bar represents CD4+YFP- T cells. The results represent the mean+/-SD of relative expression values for the indicated genes relative to hypoxanthine-guanine phosphoribosyl transferase. Data are representative of three independent experiments.
Figure 4
Figure 4. Increased Treg cell activation and selective dysregulation of Th17 cell responses in Foxp3CreIl10rafl/fl mice
(A) Flow cytometric analysis of Treg cell activation markers and putative effector molecules on splenic CD4+Foxp3+ T cells in Foxp3CreIl10rafl/fl and control littermate mice. (B, C) Flow cytometric analysis of cytokine production by splenic CD4+Foxp3- T cells in Foxp3CreIl10rafl/wt and Foxp3CreIl10rafl/fl mice after PMA and Ionomycin treatment for 4-6 hours (** p<0.001; * p<0.01).
Figure 5
Figure 5. IL-10R-deficient Treg cells efficiently control in vitro T cell proliferation but fail to suppress Th17 cell differentiation and colitis
(A) IL-10R-deficient and -sufficient Treg cell-mediated suppression of effector T cell (TEff) proliferative responses in vitro. (B) Frequencies of Th1, Th2 and Th17 skewed cells among the transferred T cell population isolated from the Foxp3- mice. (C) Frequencies of splenic Treg cells, CD4+IL-17+Foxp3- T cells, CD4+IFN-γ+ Foxp3- T cells, and CD4+IL-4+Foxp3- T cells within the indicated donor-derived population 5-6 weeks after co-transfer of either Foxp3CreIl10rafl/wt or Foxp3CreIl10rafl/fl Treg cells with Foxp3- CD4+ T cells into Rag2-/- recipients. (D) Representative H&E stained sections of colon collected from recipient mice 5-6 week after adoptive T cell transfer (original magnification, 10x). Note: Mucosa (M), submucosal edema (E), dilated lymphatics (*) and lumen (L).
Figure 6
Figure 6. IL-10R signaling is required for IL-10 expression by Treg cells
(A) qPCR analysis of STAT3-bound chromatin isolated from wild type Treg cells using primers corresponding to the indicated genes. House-keeping gene Gmpr was used as a specificity control while IgG-immunoprecipitated chromatin was used as a negative control. (B) qPCR analysis of relative expression of indicated genes in Treg cells isolated from either Foxp3CreIl10rafl/wt or Foxp3CreIl10rafl/fl mice. The results represent the mean+/-SD of relative expression values for the indicated genes relative to hypoxanthineguanine phosphoribosyl transferase.

Comment in

References

    1. Adamson AS, Collins K, Laurence A, O'Shea JJ. The Current STATus of lymphocyte signaling: new roles for old players. Curr Opin Immunol. 2009;21:161–166. - PMC - PubMed
    1. Ahern PP, Izcue A, Maloy KJ, Powrie F. The interleukin-23 axis in intestinal inflammation. Immunol Rev. 2008;226:147–159. - PubMed
    1. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut. 2009;58:1152–1167. - PubMed
    1. Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2001;281:G764–778. - PubMed
    1. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, Rudensky AY. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. 2009;326:986–991. - PMC - PubMed

Publication types